Ezetimibe
Brand name: Ezetimibe
Rank #138 of 500 drugs by total cost
$118.1M
Total Cost
2,859,001
Total Claims
$118.1M
Total Cost
60,846
Prescribers
$41
Cost per Claim
681,047
Beneficiaries
7,056,413
30-Day Fills
$1,941
Avg Cost/Provider
47
Avg Claims/Provider
About Ezetimibe
Ezetimibe (sold as Ezetimibe) was prescribed 2,859,001 times by 60,846 Medicare Part D providers in 2023, costing the program $118.1M. At $41 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology